EVOFEM BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
EVOFEM BIOSCIENCES, INC. (EVFM) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -3.16% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2025-03-24
- EVOFEM BIOSCIENCES, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was -3.16%, a 203.95% decline from fiscal 2023.
- EVOFEM BIOSCIENCES, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was 3.04%.
- EVOFEM BIOSCIENCES, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was -1.82%.
- EVOFEM BIOSCIENCES, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2021 was -0.70%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -3.16% 10-K · filed 2025-03-24 | |
| 2023-12-31 | 3.04% 10-K · filed 2025-03-24 | |
| 2022-12-31 | -1.82% 10-K · filed 2024-03-27 | |
| 2021-12-31 | -0.70% 10-K · filed 2023-04-27 | |
| 2020-12-31 | -0.76% 10-K · filed 2022-03-10 | |
| 2019-12-31 | -0.58% 10-K · filed 2021-03-04 | 0.58% 10-K · filed 2020-03-12 |
| 2018-12-31 | 1.03% 10-K · filed 2020-03-12 | |
| 2017-12-31 | 2.93% 10-K · filed 2019-03-01 | -22.68% 8-K/A · filed 2018-04-06 |
| 2016-12-31 | -17.34% 8-K/A · filed 2018-04-06 |